C-Rad AB (publ) (STO: CRAD.B)

Market Cap	1.46B
Revenue (ttm)	497.02M
Net Income (ttm)	53.53M
Shares Out	33.58M
EPS (ttm)	1.58
PE Ratio	27.62
Forward PE	19.21
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,782
Open	42.20
Previous Close	42.65
Day's Range	42.20 - 43.60
52-Week Range	27.00 - 49.95
Beta	1.01
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2024

About C-Rad AB

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the America, and the Asia Pacific. Its products include Sentinel 4DCT, a laser-based optical surface scanning system; Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Catalyst+ PT, a s...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 94
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: CRAD.B

Financial Performance

In 2023, Midsona AB's revenue was 3.79 billion, a decrease of -2.72% compared to the previous year's 3.90 billion. Losses were -53.00 million, -89.42% less than in 2022.